TY - JOUR
T1 - Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus
AU - Arbelaez, Ana Maria
AU - Xing, Dongyuan
AU - Cryer, Philip E.
AU - Kollman, Craig
AU - Beck, Roy W.
AU - Sherr, Jennifer
AU - Ruedy, Katrina J.
AU - Tamborlane, William V.
AU - Mauras, Nelly
AU - Tsalikian, Eva
AU - Wilson, Darrell M.
AU - White, Neil H.
PY - 2014/3
Y1 - 2014/3
N2 - Context: Glycemic control is limited by the barrier of hypoglycemia. Recurrent hypoglycemia impairs counterregulatory (CR) hormone responses to subsequent hypoglycemia. Objective: To determine the glucagon and epinephrine responses to insulin-induced hypoglycemia in adolescents with recent-onset type 1 diabetes mellitus (T1DM). Methods: We assessed the CR responses to hypoglycemia by performing a hyperinsulinemic (2.0mU/kg/min), euglycemic (BG 90mg/dL; 5.0mmol/L)-hypoglycemic (BG 55mg/dL; 3.0mmol/L) clamp in 25 recent-onset (<1 yr duration) patients 9-18 yr old (mean±SD: 13.4±2.7) with T1DM and 16 non-diabetic controls 19-25 yr old (mean±SD 23.3±1.8). Twenty of the T1DM subjects were retested 1-yr (53±3 wk) later. Results: At the initial and 1-yr studies, peak glucagon (pGON) and incremental glucagon (ΔGON) during hypoglycemia were lower in the T1DM subjects [median pGON=47pg/mL (quartiles: 34, 72), ΔGON=16 (4, 27) initially and pGON=50pg/mL (42, 70), ΔGON=12 (9, 19) at 1-yr] than in controls [pGON=93pg/mL (60, 111); ΔGON=38pg/mL (19, 66), p=0.01 and p=0.004 for ΔGON at initial and 1-yr study, respectively]. In contrast, peak epinephrine (pEPI) and incremental epinephrine (ΔEPI) levels were similar in the T1DM (pEPI=356pg/mL (174, 797) and ΔEPI=322pg/mL (143, 781) initially and pEPI=469pg/mL (305, 595) and ΔEPI=440pg/mL (285, 574) at 1 yr) and in controls (pEPI=383pg/mL (329, 493) and ΔEPI=336pg/mL (298, 471) p=0.97 and 0.21 for ΔEPI at initial and 1-yr study, respectively). Conclusions: Even within the first year of T1DM, glucagon responses to hypoglycemia are blunted but epinephrine responses are not, suggesting that the mechanisms involved in the loss of these hormonal responses, which are key components in pathophysiology of hypoglycemia-associated autonomic failure, are different.
AB - Context: Glycemic control is limited by the barrier of hypoglycemia. Recurrent hypoglycemia impairs counterregulatory (CR) hormone responses to subsequent hypoglycemia. Objective: To determine the glucagon and epinephrine responses to insulin-induced hypoglycemia in adolescents with recent-onset type 1 diabetes mellitus (T1DM). Methods: We assessed the CR responses to hypoglycemia by performing a hyperinsulinemic (2.0mU/kg/min), euglycemic (BG 90mg/dL; 5.0mmol/L)-hypoglycemic (BG 55mg/dL; 3.0mmol/L) clamp in 25 recent-onset (<1 yr duration) patients 9-18 yr old (mean±SD: 13.4±2.7) with T1DM and 16 non-diabetic controls 19-25 yr old (mean±SD 23.3±1.8). Twenty of the T1DM subjects were retested 1-yr (53±3 wk) later. Results: At the initial and 1-yr studies, peak glucagon (pGON) and incremental glucagon (ΔGON) during hypoglycemia were lower in the T1DM subjects [median pGON=47pg/mL (quartiles: 34, 72), ΔGON=16 (4, 27) initially and pGON=50pg/mL (42, 70), ΔGON=12 (9, 19) at 1-yr] than in controls [pGON=93pg/mL (60, 111); ΔGON=38pg/mL (19, 66), p=0.01 and p=0.004 for ΔGON at initial and 1-yr study, respectively]. In contrast, peak epinephrine (pEPI) and incremental epinephrine (ΔEPI) levels were similar in the T1DM (pEPI=356pg/mL (174, 797) and ΔEPI=322pg/mL (143, 781) initially and pEPI=469pg/mL (305, 595) and ΔEPI=440pg/mL (285, 574) at 1 yr) and in controls (pEPI=383pg/mL (329, 493) and ΔEPI=336pg/mL (298, 471) p=0.97 and 0.21 for ΔEPI at initial and 1-yr study, respectively). Conclusions: Even within the first year of T1DM, glucagon responses to hypoglycemia are blunted but epinephrine responses are not, suggesting that the mechanisms involved in the loss of these hormonal responses, which are key components in pathophysiology of hypoglycemia-associated autonomic failure, are different.
KW - Children
KW - Counterregulation
KW - Epinephrine
KW - Glucagon
KW - Hypoglycemia
KW - Type 1 diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=84896396111&partnerID=8YFLogxK
U2 - 10.1111/pedi.12070
DO - 10.1111/pedi.12070
M3 - Article
C2 - 23992543
AN - SCOPUS:84896396111
SN - 1399-543X
VL - 15
SP - 127
EP - 134
JO - Pediatric Diabetes
JF - Pediatric Diabetes
IS - 2
ER -